The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ocumension Therapeutics since 2023.
This trader's CIK number is 1840315.
At the time of last reporting, Ocumension Therapeutics was the Director of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYEP).
Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | EYEP | 0 | $0 | 1,910,500 | $37,159,225 | 0 | $0 |
| 2023 | EYEP | 0 | $0 | 1,000,000 | $19,510,636 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-11 | EYEP | Sale | 1,910,500 | 19.45 | 37,159,225 |
| 2023-12-06 | EYEP | Sale | 266,242 | 18.41 | 4,901,515 |
| 2023-12-05 | EYEP | Sale | 733,758 | 19.91 | 14,609,121 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ocumension Therapeutics (Director of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.